Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Calcitonin-Salmon (Miacalcin) Peptide
32-amino-acid peptide for osteoporosis and hypercalcemia.
What is Calcitonin-Salmon (Miacalcin)?
Calcitonin-Salmon (Miacalcin) is a calcitonin · bone resorption peptide studied for postmenopausal osteoporosis (>5 yrs postmenopause) and paget's disease. Below is an educational overview of Calcitonin-Salmon (Miacalcin) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.
Plain-Language Label Highlights
Brand names: Miacalcin, Fortical (nasal)
Postmenopausal osteoporosis (nasal/injectable), Paget's disease, hypercalcemia.
A hormone nasal spray or injection that lowers blood calcium and reduces bone breakdown.
- •Nasal irritation/rhinitis (nasal form)
- •Nausea
- •Flushing
- •Injection-site reactions
- •FDA caution: possible small increased malignancy signal with long-term use
- •Allergic reactions including anaphylaxis
- •Known hypersensitivity to salmon calcitonin
Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.
Calcitonin-Salmon (Miacalcin) Mechanism of Action
Synthetic salmon calcitonin inhibits osteoclast-mediated bone resorption and promotes renal calcium excretion. Available as nasal spray or injection.
Calcitonin-Salmon (Miacalcin) Research Areas & Benefits
Calcitonin-Salmon (Miacalcin) Dosage & Common Research Protocols
200 IU intranasally daily, alternating nostrils.
100 IU SC/IM daily for Paget's.
Protocols summarized for educational reference from published research. Not dosing guidance.
Calcitonin-Salmon (Miacalcin) Studies & Cited Research
PROOF study
Reduced vertebral fracture risk in postmenopausal osteoporosis.
Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.
Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).
Calcitonin-Salmon (Miacalcin) Side Effects & Safety Considerations
- •FDA-approved.
- •FDA cautions about possible malignancy signal with long-term use.
Explore more peptides
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.